Closing the Gap in Care in Seronegative Inflammatory Arthritis

NCT01749618 | Completed

• 1 other identifier: Metrix II
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 9

Brief Summary

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Conditions

SpA; PsA

Keywords

Seronegative Inflammatory Arthritis; SpA; PsA; Randomized; Behavioural Change

Outcome Measures

Primary Outcomes (1)

• Improvement of Systematic Assessments

  Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded.

  November 2012 - November 2013

Study Arms (2)

No education or feedback

NO INTERVENTION

Rheumatologists randomized to this treatment arm receive no additional education or feedback about their systematic assessments of patients

Education and Feedback

EXPERIMENTAL

Rheumatologists randomized to receive education and feedback participate in six web conferences designed to improve their systematic assessments of their patients, and are given feedback about their performances

Behavioral: Education and Feedback

Interventions

Education and Feedback BEHAVIORAL

Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.

Education and Feedback

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Canadian Rheumatologist

Sponsors & Collaborators

• Pope Research Corporation: lead
• Academic Medical Organization of Southwestern Ontario: collaborator
• Abbott: collaborator

Study Sites (9)

Dr. Vandana Ahluwalia

Brampton, Ontario, Canada

Location

Dr. Sanjay Dixit

Burlington, Ontario, L7L 0B7, Canada

Location

Dr Pauline Boulos

Hamilton, Ontario, L8N 1Y2, Canada

Location

Dr. Nikhil Chopra

London, Ontario, N6B 2E8, Canada

Location

Dr Angela Montgomery

Mississauga, Ontario, L5B 2P7, Canada

Location

Credit Valley Rheumatology

Mississauga, Ontario, L5M 2V8, Canada

Location

The Medical Centre

Peterborough, Ontario, K9J 7B3, Canada

Location

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

Dr. Arthur Karasik

Toronto, Ontario, M9C 5N2, Canada

Location

MeSH Terms

Interventions

Educational Status

Intervention Hierarchy (Ancestors)

Socioeconomic Factors; Population Characteristics

Study Officials

• Janet E Pope, MD, MPH, FRCPC

  Pope Research Corp., St. Joseph's Health Care, Western University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 6, 2012
• First Posted: December 17, 2012
• Study Start: November 1, 2012
• Primary Completion: November 1, 2016
• Study Completion: November 1, 2016
• Last Updated: April 7, 2017

Record last verified: 2017-04

Locations

CA (9)